close 74% jaeinvestorite kontodest jääb antud teenusepakkuja juures hinnavahelepingutega kauplemisel kahjumisse. Investeerimisega kaasnevad riskid ja need ei ole sobilikud kõigile investoritele. Hinnavahelepingud on keerukad instrumendid, millega kaasneb võimenduse tõttu suur risk kaotada raha kiiresti. 74% jaeinvestorite kontodest jääb antud teenusepakkuja juures hinnavahelepingutega kauplemisel kahjumisse. Palume teil kaaluda, kas hinnavahelepingute süsteem on teile arusaadav ja kas olete valmis võtma riski, mis suure tõenäoususega on kahjumlik.
Change languageEesti
Ülevaade

MDT

87.92

-0.94%↓

A

115.46

-1.22%↓

VEEV

157.06

-5.63%↓

HQY

83.88

+2.36%↑

TLRY

6.71

-0.3%↓

MDT

87.92

-0.94%↓

A

115.46

-1.22%↓

VEEV

157.06

-5.63%↓

HQY

83.88

+2.36%↑

TLRY

6.71

-0.3%↓

MDT

87.92

-0.94%↓

A

115.46

-1.22%↓

VEEV

157.06

-5.63%↓

HQY

83.88

+2.36%↑

TLRY

6.71

-0.3%↓

MDT

87.92

-0.94%↓

A

115.46

-1.22%↓

VEEV

157.06

-5.63%↓

HQY

83.88

+2.36%↑

TLRY

6.71

-0.3%↓

MDT

87.92

-0.94%↓

A

115.46

-1.22%↓

VEEV

157.06

-5.63%↓

HQY

83.88

+2.36%↑

TLRY

6.71

-0.3%↓

Kodu・Aktsiate loetelu・CorMedix Inc
Search

CorMedix Inc

Suletud

SektorTervishoid

7.35 1.66

Tugev "osta" hinnang

Hinna uuendus 9. apr 2026, 19:59 UTC

OstaMüü

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

7.17

Max

7.37

Põhinäitajad

By Trading Economics

Sissetulek

-95M

14M

Müük

24M

129M

P/E

Sektori keskmine

3.471

66.418

Aktsiakasum

0.16

Kasumimarginaal

10.901

Töötajad

191

EBITDA

9.2M

66M

Soovitused

By TipRanks

Soovitused

Tugev "osta" hinnang

12 kuu keskmine prognoos

+83.26% upside

Dividendid

By Dow Jones

Järgmine tulemuste avaldamine

5. mai 2026

Turustatistika

By TradingEconomics

Turukapital

-8.4M

560M

Eelmine avamishind

5.69

Eelmine sulgemishind

7.35

Uudiste sentiment

By Acuity

50%

50%

168 / 349 Pingereas Healthcare

Tehniline skoor

By Trading Central

Kindlus

Strong Bullish Evidence

9.2 / N/A Toetus ja vastupanu

CorMedix Inc Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

8. apr 2026, 20:44 UTC

Tulu

Costco Reports 11% Growth in March Sales

DJ

Loe

8. apr 2026, 23:51 UTC

Market Talk

Global Equities Roundup: Market Talk

DJ

Loe

8. apr 2026, 23:51 UTC

Market Talk

Nikkei May Rise on Hopes for Talks to End Iran War -- Market Talk

DJ

Loe

8. apr 2026, 23:36 UTC

Market Talk
Uudisväärsed sündmused

Gold Edges Lower on Likely Technical Correction -- Market Talk

DJ

Loe

8. apr 2026, 22:56 UTC

Market Talk

Ramelius Resources May Downgrade Cost Guidance This Month -- Market Talk

DJ

Loe

8. apr 2026, 22:45 UTC

Market Talk

Constellation Brands Points to Continuing Challenges Among Hispanic Consumers -- Market Talk

DJ

Loe

8. apr 2026, 22:17 UTC

Market Talk

Applied Digital Says Its Holding Out for Quality Customers -- Market Talk

DJ

Loe

8. apr 2026, 21:52 UTC

Uudisväärsed sündmused

A Closer Look at Iran's 10 Demands -- and Which the U.S. Might Accept -- Update

DJ

Loe

8. apr 2026, 21:24 UTC

Tulu

FedEx Freight Aims for 12% Profit Growth. How That Compares to the Leader. -- Barrons.com

DJ

Loe

8. apr 2026, 21:01 UTC

Uudisväärsed sündmused

Oil Prices Tumble Despite Conflicting Reports About the Strait of Hormuz -- Barrons.com

DJ

Loe

8. apr 2026, 20:50 UTC

Market Talk

Energy & Utilities Roundup: Market Talk

DJ

Loe

8. apr 2026, 20:43 UTC

Omandamised, ülevõtmised, äriostud

Oracle Is Expressing No Opinion and Is Neutral as to Whether Stockholders Should Tender Their Shrs in Response to TRC's Offer >ORCL

DJ

Loe

8. apr 2026, 20:43 UTC

Omandamised, ülevõtmised, äriostud

Oracle Does Not Endorse TRC's Mini-Tender Offer or the Offer Documentation >ORCL

DJ

Loe

8. apr 2026, 20:43 UTC

Omandamised, ülevõtmised, äriostud

Oracle: Offer Represents Less Than 0.04% of Outstanding Common Stk >ORCL

DJ

Loe

8. apr 2026, 20:42 UTC

Omandamised, ülevõtmised, äriostud

Oracle: TRC Offer Is to Purchase Up to 1M Shrs of Common Stk at $140.50/Shr in Cash >ORCL

DJ

Loe

8. apr 2026, 20:42 UTC

Omandamised, ülevõtmised, äriostud

Oracle Received Notice of Unsolicited Mini-Tender Offer by TRC Dated March 24 >ORCL

DJ

Loe

8. apr 2026, 20:42 UTC

Omandamised, ülevõtmised, äriostud

Oracle Responds to TRC Cap Mini-Tender Offer

DJ

Loe

8. apr 2026, 20:15 UTC

Market Talk

Global Commodities Roundup: Market Talk

DJ

Loe

8. apr 2026, 20:11 UTC

Omandamised, ülevõtmised, äriostud

Intel Corp.: Repurchased 49% Equity Interest in JV Related to Intel's Fab 34 in Ireland >INTC

DJ

Loe

8. apr 2026, 20:11 UTC

Omandamised, ülevõtmised, äriostud

Intel Corp.: $14.2B Repurchase Price Financed with Cash on Hand and a Bridge Loan of $6.5B >INTC

DJ

Loe

8. apr 2026, 20:11 UTC

Omandamised, ülevõtmised, äriostud

Intel Corp.: Repurchased JV Stake From Apollo-Managed Funds and Affiliates >INTC

DJ

Loe

8. apr 2026, 19:44 UTC

Tulu

These Companies Pay 5% Dividend Yields, and They're Hiking Them Too -- Barrons.com

DJ

Loe

8. apr 2026, 19:16 UTC

Market Talk

Hogs Follow Cutout Prices Lower -- Market Talk

DJ

Loe

8. apr 2026, 19:02 UTC

Market Talk

Global Energy Roundup: Market Talk

DJ

Loe

8. apr 2026, 19:02 UTC

Market Talk

Oil Futures Plunge as Cease-Fire Raises Hopes for Restored Supply -- Market Talk

DJ

Loe

8. apr 2026, 18:58 UTC

Market Talk

U.S. Natural Gas Futures Fall in Line With Slump in Oil -- Market Talk

DJ

Loe

8. apr 2026, 18:51 UTC

Market Talk

Global Equities Roundup: Market Talk

DJ

Loe

8. apr 2026, 18:51 UTC

Market Talk

Levi Strauss CEO Says Expanded Offerings, DTC Focus Are Working -- Market Talk

DJ

Loe

8. apr 2026, 18:14 UTC

Uudisväärsed sündmused

Fed Minutes Suggest a Lengthy Iran War Could Lead to Rate Hikes -- Barrons.com

DJ

Loe

8. apr 2026, 18:05 UTC

Uudisväärsed sündmused

Oil Prices Continue to Tumble After Cease-Fire Despite Slow Reopening of Strait of Hormuz -- Barrons.com

DJ

Loe

Võrdlus sarnastega

Hinnamuutus

CorMedix Inc Prognoos

Hinnasiht

By TipRanks

83.26% tõus

12 kuu keskmine prognoos

Keskmine 13.25 USD  83.26%

Kõrge 14 USD

Madal 13 USD

Põhineb 5 Wall Streeti analüütiku instrumendi CorMedix Inc 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Tugev "osta" hinnang

5 ratings

5

Osta

0

Hoia

0

Müü

Põhineb 5 analüütiku instrumendi CorMedix Inc aktsia reitingul - viimase 3 kuu andmed.

Tehniline skoor

By Trading Central

9.2 / N/AToetus ja vastupanu

Lühikene perspektiiv

Strong Bullish Evidence

Recent bullish events outweigh bearish events.

Keskpikk perspektiiv

Weak Bullish Evidence

Recent bullish events outweigh bearish events.

Pikk perspektiiv

Strong Bullish Evidence

All events are bullish.

Sentiment

By Acuity

168 / 349 Pingereas Tervishoid

Uudiste sentiment

Neutral

Volatiilsus

Alla keskmise

Uudismaht (RCV)

Alla keskmise

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

$

Ettevõttest CorMedix Inc

CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States. Its lead product candidate is DefenCath, an antimicrobial catheter lock solution to reduce the incidence of catheter-related bloodstream infections in adult patients with kidney failure. The company was formerly known as Picton Holding Company, Inc. and changed its name to CorMedix, Inc. in January 2007. CorMedix Inc. was incorporated in 2006 and is based in Berkeley Heights, New Jersey.

Muud aktsiad sektorist

MDT

Medtronic PLC

87.92

↓-0.94%

A

Agilent Technologies Inc

115.46

↓-1.22%

VEEV

Veeva Systems Inc

157.06

↓-5.63%

HQY

HealthEquity Inc

83.88

↑ +2.36%

TLRY

Tilray Brands Inc

6.71

↓-0.3%
help-icon Live chat